Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT04615845
What this trial is testing

Autologous Dendritic Cell Immunotherapy in Patients With mCRPC

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Pharmicell Co., Ltd. 3
Large-scale testing (Phase 3)Study completedNCT01810770
What this trial is testing

Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis

Who this might be right for
Prostatic Neoplasms
Bayer 243
Testing effectiveness (Phase 2)Study completedNCT00278070
What this trial is testing

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Who this might be right for
Breast CancerNon Small Cell Lung CancerProstate Cancer
Hellenic Cooperative Oncology Group
Not applicableStudy completedNCT03160794
What this trial is testing

Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy

Who this might be right for
Post Prostatectomy
University Health Network, Toronto 150
Testing effectiveness (Phase 2)Study completedNCT03199872
What this trial is testing

RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours

Who this might be right for
Prostate Cancer
RhoVac APS 22
Testing effectiveness (Phase 2)Looking for participantsNCT05404139
What this trial is testing

Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)

Who this might be right for
Metastatic Prostate Cancer
University Health Network, Toronto 352
Testing effectiveness (Phase 2)UnknownNCT02935205
What this trial is testing

Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 38
Testing effectiveness (Phase 2)Study completedNCT03568656
What this trial is testing

Study to Evaluate CCS1477 in Advanced Tumours

Who this might be right for
Metastatic Castration-Resistant Prostate CancerMetastatic Breast CancerNon-small Cell Lung Cancer+1 more
CellCentric Ltd. 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT06212583
What this trial is testing

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 88
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Looking for participantsNCT07181161
What this trial is testing

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 283
Large-scale testing (Phase 3)Study completedNCT00036556
What this trial is testing

Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Abbott 941
Not applicableStudy completedNCT01062503
What this trial is testing

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC

Who this might be right for
Metastatic Prostate CancerBone Metastasis
University Health Network, Toronto 48
Testing effectiveness (Phase 2)WithdrawnNCT01087580
What this trial is testing

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Who this might be right for
PROSTATE CANCER
Northwestern University
Testing effectiveness (Phase 2)WithdrawnNCT02906605
What this trial is testing

The Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT01487720
What this trial is testing

GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Asan Medical Center 33
Not applicableStudy completedNCT03087903
What this trial is testing

Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 41
Not applicableTemporarily pausedNCT07146113
What this trial is testing

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

Who this might be right for
Prostate Cancer
AstraZeneca 400
Early research (Phase 1)Study completedNCT04428788
What this trial is testing

Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Celgene 131
Next Page